K. Hatakeyama

p53 Immunostaining distinguishes malignant from benign lesions of the gall‐bladder

H. Watanabe, Y. Ajioka, Y. Oohashi, 1995, Pathology international.

Expression of Fas ligand is an early event in colorectal carcinogenesis

K. Hatakeyama, K. Hatakeyama, T. Kanda, 2001, Journal of surgical oncology.

Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile.

H. Watanabe, Y. Ajioka, J. Hitomi, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[Genetic alterations in gallbladder carcinoma: a review].

H. Kijima, H. Watanabe, Y. Ajioka, 1998, Nihon Geka Gakkai zasshi.

Alteration of p53 Clonality Accompanying Colorectal Cancer Progression

H. Kijima, Y. Ajioka, K. Hatakeyama, 1998, Japanese journal of cancer research : Gann.

Malignant islet cell tumor projecting into the main pancreatic duct.

Y. Ajioka, K. Hatakeyama, O. Sato, 2000, Journal of hepato-biliary-pancreatic surgery.

Expression of p73 in Colorectal Carcinoma: Clinicopathological Relevance

K. Hatakeyama, X. Cui, L. Liu, 2001, The Journal of international medical research.